prevail
therapeutics
present
oppenheimer
fall
healthcare
life
sciences
medtech
summit
new
york
globe
newswire
prevail
therapeutics
nasdaq
prvl
biotechnology
company
developing
potentially
gene
therapies
patients
neurodegenerative
diseases
today
announced
asa
abeliovich
founder
chief
executive
officer
prevail
present
virtual
oppenheimer
fall
healthcare
life
sciences
medtech
summit
tuesday
september
et
webcast
available
events
presentations
section
company
website
webcast
archived
days
following
presentation
prevail
therapeutics
prevail
gene
therapy
company
leveraging
breakthroughs
human
genetics
goal
developing
commercializing
gene
therapies
patients
neurodegenerative
diseases
company
developing
patients
parkinson
disease
mutations
neuronopathic
gaucher
disease
patients
frontotemporal
dementia
grn
mutations
patients
certain
synucleinopathies
prevail
founded
asa
abeliovich
collaborative
effort
silverstein
foundation
parkinson
gba
orbimed
headquartered
new
york
ny
statements
related
prevail
statements
contained
press
release
regarding
matters
historical
facts
statements
within
meaning
private
securities
litigation
reform
act
amended
examples
statements
include
statements
concerning
potential
prevail
gene
therapy
candidates
transform
treatment
patients
slow
halt
progression
neurodegenerative
diseases
statements
subject
risks
uncertainties
actual
results
may
differ
materially
expressed
implied
statements
risks
uncertainties
include
among
others
prevail
novel
approach
gene
therapy
makes
difficult
predict
time
cost
potential
success
product
candidate
development
regulatory
approval
prevail
gene
therapy
programs
may
meet
safety
efficacy
levels
needed
support
ongoing
clinical
development
regulatory
approval
regulatory
landscape
gene
therapy
rigorous
complex
uncertain
subject
change
fact
gene
therapies
novel
complex
difficult
manufacture
risks
relating
impact
business
pandemic
similar
public
health
crises
risks
described
fully
prevail
filings
securities
exchange
commission
sec
including
risk
factors
section
company
quarterly
report
form
period
ended
june
filed
sec
august
documents
subsequently
filed
furnished
sec
statements
contained
press
release
speak
date
made
except
extent
required
law
prevail
undertakes
obligation
update
statements
reflect
events
occur
circumstances
exist
date
made
media
contact
mary
carmichael
ten
bridge
communications
mary
investor
contact
investors
